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The  study  concerns  about  the  crystallization  behaviour  and in  vitro  bioactivity  of  a glass-ceramic  pre-
pared  from  a series  of  glasses  in the  Na2O–K2O–CaO–SiO2–F system.  A  minor  amount  of cerium  oxide  was
also  added  instead  of  calcium  oxide  in some  selective  glass  batches.  The  main  crystalline  phases,  formed
after  the  appropriate  heat  treatments,  were  wollastonite  solid  solution  and  pseudo-wollastonite-like
phases.  There  is  a preferential  tendency  for wollastonite  (CaSiO3)  to accommodate  K,  Na,  F,  and  Ce  ions  in
its structure  forming  wollastonite  solid  solution  with  variable  formulas.  The  bioactivity  of  the  resulting
crystalline  materials  was examined  in vitro by  immersion  in simulated  body  ﬂuid at  37 ◦C. An increase  ofrystallization
lass-ceramics
ollastonite
iomaterials
the  surface  bioactivity  of glass-ceramic  with  the  Na2O/K2O replacement  was  observed  which  is  attributed
to  the augmentation  solubility  of the  crystalline  sample.  On the  other  hand,  the  bioactivity  of  the  crys-
talline  sample  with CeO2/CaO replacement  was  improved  by the crystallization  of pseudo-wollastonite
phase together  with  wollastonite  solid  solution  phase.
©  2015  The  Ceramic  Society  of  Japan  and  the Korean  Ceramic  Society.  Production  and  hosting  by. Introduction
Glass-ceramics are produced by controlled nucleation and
rystallization of glasses. The great varieties of compositions
nd microstructures with speciﬁc technological properties have
llowed glass-ceramics to be used in a wide range of applications
1]. There is great interest in glass-ceramics that possess appropri-
te physical, mechanical, and biological properties for biomedical
pplications. These materials should be biocompatible and in most
ases bioactive. Bioactivity is deﬁned as the ability of biomateri-
ls to promote the formation of a crystalline hydroxyl apatite (HA)
ayer from physiological ﬂuid [2]. In implantology, there is consid-
rable interest in bioactive materials to establish strong chemical
onding between the implant and bone, as well as to accelerate
mplant anchorage by inducing an HA layer on the implant surface
3]. Currently, several bioactive glass-ceramics are used for clini-
al applications as middle-ear implant for the reconstruction of the
liac crest and also as vertebral prostheses or dental implants [4].∗ Corresponding author. Tel.: +20 233371362; fax: +20 233370931;
obile: +20 1146027924.
E-mail address: ha.ebrahim@nrc.sci.eg (H.A. Abo-Mosallam).
Peer review under responsibility of The Ceramic Society of Japan and the Korean
eramic Society.
ttp://dx.doi.org/10.1016/j.jascer.2015.04.004
187-0764 © 2015 The Ceramic Society of Japan and the Korean Ceramic Society. ProducElsevier  B.V.  All  rights  reserved.
Wollastonite (CaSiO3) or calcium metasilicate is a chain silicate
mineral. As it is known, calcium silicate has mainly two normal
modiﬁcations, one is the low temperature phase wollastonite and
the other is the high temperature phase pseudo-wollastonite [5].
By heating over 1125 ◦C, during the sintering, the low temperature
form of wollastonite transformed reconstructively into pseudo-
wollastonite [6]. Since the 1990s, wollastonite (CaSiO3) ceramics
have been studied as biomaterials for artiﬁcial bones and dental
roots because wollastonite exhibits good bioactivity and biocom-
patibility. Some investigators have reported that wollastonite and
pseudo-wollastonite ceramics are bioactive and observed that the
formation of apatite on CaSiO3 ceramics is faster than that on
other bioglass and glass-ceramics in simulated body ﬂuids (SBF)
[5]. Siriphannon et al. [7] have found that the rate of hydroxyap-
atite (HA) formation on pure CaSiO3 ceramic surface was  faster than
that on the biocompatible apatite wollastonite A/W glass-ceramics
and some other bioactive glass-ceramics.
Fluorosilicate glass-ceramics are characterized by unique
mechanical properties dependent upon highly anisotropic crys-
tals, which assume one- or two-dimensional form. Thus, mica
glass-ceramic displays mechanical machineability, whereas
glass-ceramic based on amphibole and other chain silicates
has shown extreme strength and toughness. Fluorosilicates-
containing glass-ceramics are characterized as being less
sensitive to superﬁcial damages and exhibit higher thermal
shock, erosion and fracture strength than common ceramic
tion and hosting by Elsevier B.V. All rights reserved.
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aterials [8]. Several noteworthy synthetic glass-ceramics have
een developed based on ﬂuorosilicates crystalline phases:
otassium ﬂuorphlogopite (KMg3AlSi3O10F2), ﬂuorrichterite
KNaCaMg5Si8O22F2), ﬂuorcanasite ((Na,K)6Ca5Si12O30F4), and
uor-miserite (KCa5(Si2O7)(Si6O15)(OH)F, where  denotes a
acancy or “virtual site” within the structure [8]. The miserite crys-
alline phase, which strengthens glass-ceramic materials, has been
escribed as a pyroxenoid (wollastonite) or hydrous pyroxenoid
erivative (pectolite). It is anticipated that miserite glass-ceramic
as biocompatibility, bioactivity, and excellent machineability.
hus, miserite glass-ceramic is a promising biomaterial for dental
mplant applications as an alternative to metallic titanium, due
o its biological, mechanical and optical properties [9]. Another
nteresting ﬂuorine-containing crystalline phase in glass-ceramics
s cuspidine (Ca4Si2O7F2), a sorosilicate with isolated (Si2O7)6−
ouble tetrahedral groups. Cuspidine is the most abundant high
emperature phase in mould ﬂuxes used in continuous casting of
teel [10].
In order to enhance the capability of sensitivity of bioglass reac-
ions in vivo, the glass could be doped with a luminescent rare earth
RE). Cerium is known to possess bacteriostatic properties and low
oxicity [11]. It has been reported [12] that the activity of cerium (III)
ulfadiazine against various microorganisms is comparable to that
f silver sulfadiazine and cerium-doped bioactive glasses. It could
e useful when implantation concerns with periodontal pockets,
nfected frontal sinuses, and hypersensitive teeth as a complica-
ion of periodontal treatment or tooth wear that has resulted in the
xposure of dentine and dental tubules [13].
The main purpose of the present paper is to study the effect of
ompositional changes on crystallization behaviour and the in vitro
ioactivity for a series of glasses based on Na2O–K2O–CaO–SiO2–F
lass system with different Na2O/K2O replacement ratio. Minor
mount of cerium oxide CeO2 was introduced in the glass formula
t the expense of calcium. This work is concerned with the fun-
amental knowledge for the type of phases, solid solutions, and
he microstructure formed in the glass-ceramic materials and their
iological behaviour.
. Materials and methods
The compositions of glasses studied are listed in Table 1. Analyt-
cal grade reagents Na2CO3, K2CO3, CaCO3, CaF2, CeO2, and Quartz
SiO2) were used as starting materials. The homogeneous weighed
atch materials (100 g), after thorough mixing, were preheated at
000 ◦C for 1 h for calcination and to avoid the volatilization. The
elting process was performed in a platinum crucible in a Vecstar
lectric furnace at 1400–1450 ◦C for 1.5 h. The melts were then cast
nto hot stainless steel moulds. The glasses were annealed at 500 ◦C
or 1 h, and then the mufﬂe furnace cooled to room temperature to
emove the residual thermal stress.
The thermal behaviour of glasses was monitored by DTA using
 differential thermal analyzer (SDTQ 600 – TA Instruments, USA)
o know the glass transition (Tg) and crystallization (Tc) tempera-
ures and to determine the optimum conditions for heat treatment
rocessing where the temperature ranges between 25 and 1000 ◦C.
he cast glass was crushed and sieved between 90 and 125 m
o produce glass powder suitable for DTA. About 30 mg  powdered
ample was placed in an alumina crucible and subjected to a heating
ate of 10 ◦C/min from ambient temperature to 1000 ◦C in a ﬂowing
igh purity nitrogen environment.
The progress of crystallization in the glasses was followed using
ouble stage heat-treatment regimes. Crystallization was  carried
ut at temperatures in the region of the main DTA exothermic peak
etermined for each glass. The glasses were ﬁrst heated according
o the DTA results at the endothermic peak temperature for 5 h,amic Societies 3 (2015) 255–261
which was followed by another thermal treatment at the exother-
mic  peak temperature for 10 h. To characterize the crystalline
phases of glass-ceramic samples after controlled heat treatment,
powder XRD was conducted on a diffractometer (PW1080, PANa-
lytics, Netherlands) with Cu K radiation (40 kV and 30 mA  source).
Spectra were obtained from 10◦ to 80◦ 2 at a step size of 0.02◦. The
JCPDS reference cards were used to interpret the patterns.
The microstructure observation of the glass-ceramic samples
was examined using a scanning electron microscope (Quanta
FEG 250, Netherlands) equipped with an energy dispersive X-ray
spectroscopy (EDX) system. The fracture sample surfaces were
chemically etched by immersion in a (1%HF + 1%HNO3) aqueous
solution for 60 s. After that, the samples were ultrasonically washed
with distilled water and dried in the dryer. The fracture surfaces
were coated with a thin layer of gold by sputtering method.
In order to estimate the in vitro bioactivity test of the selected
glass-ceramic specimens, we  used the SBF proposed by Kokubo
et al. [14]. The Tris-buffered SBF composition is (Na+ 142.0, K+ 5.0,
Mg2+ 1.5, Ca2+ 2.5, Cl− 147.8, HCO3− 5.0, HPO42− 1.0 and SO42−
0.5 mol  m−3). The specimens were cut by a low speed diamond disc
into rectangular pieces of dimensions (10 mm × 10 mm × 5 mm).
The samples were polished and sequentially ultrasonically washed
in isopropyl alcohol, in acetone, and in deionized water and then
air-dried. These specimens were vertically mounted on a nylon
wire in polyethylene falcon test tubes containing 50 ml  of SBF for
21 days at 37 ± 0.5 ◦C and pH = 7.2 ± 0.3, using HCl 0.1 N for pH
adjustment. The ratio of the SBF volume to the area of ceramic
was equal to 0.5 cm3 mm−2. After the immersion time the samples
were gently rinsed with deionized water and acetone and dried in
air at room temperature. The surfaces of dried samples were ana-
lyzed by (SEM–EDX) and (FTIR) to detect the appearance of HCA
layer. The glass-ceramic samples were analyzed by FTIR-6100 type
A machine (The Netherlands). The spectra were obtained between
400 and 1600 cm−1 wave number with resolution of 2 cm−1.
3. Results
3.1. Crystallization characteristics
Typical DTA of the glass samples crystallized at the heating rate
of 10 ◦C/min are shown in Fig. 1. The results indicate that the inves-
tigated glass has followed the typical behaviour of the vitreous
materials transforming into the glass-ceramic. The DTA spectrum
of each glass displays the glass transition temperature (Tg) as a
shoulder endothermic peak at which the atoms begin to arrange
themselves in preliminary structural elements subsequent to crys-
tallization. The crystallization temperature of the glass (Tc), as an
exothermic peak indicating crystallization reaction in the glasses,
are also recorded. The base glass sample G1 has a glass transition
temperature (Tg) of 705 ◦C and a crystallization temperature (Tc)
of 870 ◦C. The DTA data reveal that the addition of Na2O instead of
K2O led to shifting the endothermic dips to lower temperatures, i.e.,
lower temperature is needed to start the nucleation process in the
glasses. In contrast the DTA data (Fig. 1) reveal that the endother-
mic  dips as well as the onset of crystallization were shifted to higher
temperature with the addition of CeO2 at the expense of CaO.
In order to identify the crystalline phase’s assemblage in the
resultant glass-ceramic formed through crystallization of the stud-
ied glasses, each glass was  heat treated at its crystallization peak
temperatures (extracted from the relevant DTA thermograph) for
10 h. The phases developed in glass-ceramics as indicated by the
X-ray diffraction analysis (Figs. 2 and 3) are wollastonite solid
solution and pseudo-wollastonite. The X-ray diffraction analysis
(XRD) (Fig. 2, pattern I, Table 2) indicated that the base glass (G1)
crystallized at 705 ◦C/5 h–870 ◦C/5 h to form only monomineralic
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Table  1
The composition and the DTA data of the investigated glasses.
Sample Oxide constitutions (mol%) DTA data
K2O Na2O CaO SiO2 CaF2 CeO2 Tg Tc
G1 5.17 – 29.31 55.18 10.34 – 707 871
G1Ce 5.17 – 28.31 55.18 10.34 1.0 710 894
G2 3.45 1.72 29.31 55.18 10.34 – 695 858
G3 1.72 3.45 29.31 55.18 10.34 – 683 846
G4 0.0 5.17 29.31 55.18 10.34 – 669 817
G4Ce 0.0 5.17 28.31 55.18 10.34 1.0 676 823
Fig. 1. DTA data of the investigated glasses.
Table 2
Crystalline phases developed and the properties of the investigated glass-ceramic
samples.
Sample Heat treatment (◦C/h) Crystal phases
developed
G1 705/5–870/10 Wollastonite ss 1
G1Ce 710/5–895/10 Wollastonite
ss + pseudo-
wollastonite
G2 695/5–860/10 Wollastonite ss 2
G3 685/5–845/10 Wollastonite ss 3
G4 670/5–820/10 Wollastonite ss 4
G4Ce 675/5–825/10 Wollastonite ss 5Fig. 2. X-ray diffraction patterns of the crystallized glasses (G1–G4).
phase of wollastonite solid solution type (major lines 3.83, 3.49,
3.31, 3.08, 2.98, 2.55 JCPDS, 27-1064). The XRD analysis clearly
indicated that the diffraction lines of the solid solution formed
were identical, with a slight shift, to those of wollastonite-CaSiO3
(PDF No. 27-1064). The addition of Na2O instead of K2O in the
glasses i.e., G2, G3 and G4, revealed that the thermal treatment of
these glasses at 695 ◦C/5 h–860 ◦C/10 h, 685 ◦C/5 h–845 ◦C/10 h, and
670 ◦C/5 h–820 ◦C/10 h, respectively, led to the formation of wollas-
tonite solid solution phase as conﬁrmed by the XRD analysis (Fig. 2,
patterns II–IV).
A detailed study of the effect of CeO2/CaO replacement on
the crystal phase constitution developed in the glass-ceramic
materials (G1Ce and G4Ce) was  obtained by the X-ray diffrac-
tion analysis (XRD) (Fig. 3 and Table 2). The addition of CeO2
instead of CaO in glass G1 resulted into the crystallization of a
Fig. 3. X-ray diffraction patterns of the crystallized glasses G1, G1Ce, G4 and G4Ce.
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big. 4. SEM micrograph of fracture surface of glass-ceramic G1 (A), G4 (B), and G1Ce
C).
seudo-wollastonite-like phase (major lines 3.42, 3.23, 3.31, 2.90,
.97 JCPDS, 10-468) together with the wollastonite solid solution
Fig. 3, pattern II). Mineralogically, only wollastonite solid solution
hase was formed and no other phases could be detected by
he replacement of CaO by CeO2 in G4 as indicated from X-ray
iffraction analysis (Fig. 3, pattern IV).
Fig. 4 shows the SEM micrograph of the selected glass-ceramic
amples obtained by controlled heat-treatment conditions. The
icrostructure of the base glass-ceramic G1 (heat treated at 705 ◦C
or 5 h and 870 ◦C for 10 h) is shown in Fig. 4(A). The rod-shaped
rooves due to the detachment of wollastonite solid solution as
he only crystalline phase crystallites are clearly observed on the
tched fracture surface. The microstructure of the glass-ceramic
ample G4 (heat treated at 670 ◦C for 5 h and 815 ◦C for 10 h) is
hown in Fig. 4(B). The sample showed similar microstructure as
1 but with large size. The addition of minor amount of cerium
xide CeO2 instead of CaO in the base glass led to crystallization of
rismatic crystals beside rod-shaped crystals in crystalline sample
1Ce as shown in Fig. 4(C). The formation of prismatic crystals may
e attributed to crystallization of pseudo-wollastonite phase.amic Societies 3 (2015) 255–261
3.2. Bioactivity
The in vitro bioactivity of the glass-ceramic samples was inves-
tigated by soaking the samples in SBF. SEM images and EDX spectra
of the crystalline specimens after 21 days of immersion in the sim-
ulated body ﬂuid SBF are presented in Fig. 5. The scanning electron
micrographs of the crystalline samples show that surface spherules
layers are formed which are assumed to be due to the formation of
the apatite phase as revealed by the EDX analysis. This has resulted
from the interaction of the glass-ceramic surface with the SBF solu-
tion. The EDX analysis of G1 and G4 revealed that the presence of
Ca, Si, O, P, Na, K and Mg  could be found. The presence of Ca, Si, K, Na
and O may  be attributed to the elemental composition of the glass-
ceramic. The presence of P was  in an appreciable amount reﬂecting
the bioactivity obtained due to soaking in the SBF solution. The EDX
results showed that the Si content decreased signiﬁcantly while the
Ca and P contents increased with Na/K replacement indicating that
the layer formed on the G4 sample surface is rich in calcium and
phosphorus layer. The EDX analysis of the surface of crystalline
specimen G1Ce (Fig. 5) revealed that signiﬁcant peaks of calcium
and phosphorous were present while silicon peak disappeared.
Fig. 6 shows the FTIR spectra of the glass-ceramic samples after
soaking for 21 days in SBF solution. No signiﬁcant differences were
observed in the FTIR spectra. Phosphate absorption bands at 1025,
620, 578, and 450 cm−1 were observed in all samples, where the
double peaks at 620 and 578 cm−1 were characteristic feature of
phosphate in crystalline phases [15]. Carbonate bands at 1423 and
871 cm−1 were also detected.
4. Discussion
4.1. Crystallization characteristics
The crystallization is the process by which the regular lattice of
the crystals is generated from the less well-ordered liquid struc-
ture; it is essentially an ordering phenomenon [16]. The DTA data
give evidence that the crystallization characteristics of the glasses
were markedly improved by Na2O/K2O replacements. The addition
of sodium instead of potassium oxide modiﬁes the local structure in
glass. We  observed that the glass transition temperature Tg tends to
shift to lower temperature as the sodium oxide content is increased
at the expense of potassium oxide. This could be attributed to the
addition of sodium instead of potassium in the glasses that led to
decreasing the activation energy of the glass crystallization. On the
contrary the addition of K2O instead of Na2O in the glasses led
to the shift of both the endothermic and exothermic peak tem-
peratures towards higher temperature values, which means that a
higher energy is needed to induce crystallization in the thermally
treated glass [17]. Glass transition temperature is a characteristic of
structural relaxations taking place in the glass network and hence
strongly depends on the nature of the structural units constitut-
ing the glass network and their connection way. Wang et al. [18]
reported that the substitution of K2O for Na2O in the glass leads
to shifting of glass transition temperatures to higher values, which
enhances the thermal stability of the studied glass.
Light rare-earth elements, like Ce3+, La3+, and Pr3+, can readily be
substituted for calcium in glasses because their ionic radii are very
close to that of Ca2+ and the charge balance may  be readily main-
tained with coupled substitutions, such as 2Ca2+ = RE3+ + Na+[19].
The addition of CeO2 at the expense of CaO led to shifting both the
endothermic and exothermic peaks towards higher temperature
values, i.e. a higher energy is needed to induce crystallization in
the glass. This could be attributed to the ability of CeO2 to form
CeO4 group, these tetrahedral (CeO4) structures led to an increase
in the viscosity of the glass which hinders the diffusion of different
S.M. Salman et al. / Journal of Asian Ceramic Societies 3 (2015) 255–261 259
Fig. 5. SEM images and EDX analysis of the crystalline spe
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(Ca0.79, K0.14, Na0.7)Si(O0.88, F0.12)3 wollastonitess2
As for sample G3, the replacement of K2O by Na2O gave rise to
the development of the wollastonite solid solution which has theig. 6. FTIR of the crystallized samples after immersion in SBF solution for 21 days.
ons and ionic complexes, and consequently, it decreases the rate
f crystal growth during the crystallization of the glass resulting in
ome difﬁculty in the glass-crystal conversion [20].
Nucleation and crystallization mechanisms used in the devel-
pment of glass-ceramics are controlled by taking advantage of
arious solid state reactions. The quantiﬁcation of the different
rystalline phases is indeed important for optimizing the prop-
rties of the glass-ceramics. In order to understand and explain
he details of crystallization sequence in the most promising glass
amples, after subjecting them to controlled heat treatment condi-
ions, they were analyzed by XRD. The conditions of heat treatment
nd the crystallization products are tabulated in Table 2. The X-ray
iffraction analysis revealed that the base glass G1 crystallized intocimens after immersion in SBF solution for 21 days.
wollastonite ss phase and no other phases could be detected. The
d-spacing reﬂections of the wollastonite solid solution formed are
similar to those characteristics for wollastonite phase. This will lead
to an important conclusion that all other elements present in the
melt can ﬁnd place in the wollastonite structure [21]. Casasola et al.
[8] obtained similar results in their study on crystallization of glass
compositions in the SiO2–CaO–K2O–F glass system. They pointed
out that internal crystallization of the bulk glass samples favours
the formation of wollastonite ss phase. Wollastonite could acquire
considerable amounts of Fe2+, Mn2+, Mg2+, K+, Na+, etc. replacing
Ca2+ and Ti4+, and with Ce4+ replacing Si4+ in its structure [6]. The
radius of F− (1.36 A˚) is very close to that of O2− (1.40 A˚), so F− could
replace O2− easily. Therefore, double F− replace an O2− in the glass
network structure according to the electrostatic valence equilib-
rium rules [22]. Theoretically, [23] it is assumed therefore, that the
wollastonite ss 1 formed in the glass-ceramic of G1 has probably
the following formula:
(Ca0.79, K0.21)Si(O0.88, F0.12)3 wollastonitess1
It is well known that compositions crystallizing to give solid
solution series are important to control the properties of the
resultant materials and offer an excellent opportunity to the
glass-ceramic study [1,24]. The present results revealed that pre-
dominant wollastonite solid solution phase was developed only
from the glass-ceramic materials G2–G4. This supports the view
that sodium, potassium, and ﬂuorine ions could be incorporated
in the wollastonite structure. Theoretically, it is assumed therefore
that the wollastonite solid solution phase formed in glass-ceramic
of G2 has probably the following formula:probable formula of:
(Ca0.79, K0.7, Na0.14)Si(O0.88, F0.12)3 wollastonitess3
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The complete replacement of Na2O at the expense of K2O (i.e.
ample G4) results in a wollastonite solid solution expressed by the
ollowing formula:
Ca0.79, Na0.21)Si(O0.88, F0.12)3 wollastonitess4
The results of this study demonstrate that the partial CeO2/CaO
eplacement in the base glasses (i.e., G1Ce) favours the formation of
ollastonite ss together with a pseudo-wollastonite. The activation
nergy of pseudo-wollastonite is less than that of wollastonite. It
ollows, therefore, that pseudo-wollastonite is formed during the
rystallization of the corresponding glass in the stability ﬁeld of
ollastonite as a transitional stage between glass and the stable
ariety wollastonite [25]. Previously, it was shown that the incor-
oration of Sr into CaSiO3 increased the crystal dimension which
ay be responsible for the phase transition from wollastonite to
seudo-wollastonite-like phase [24,26]. On the other hand, in case
f the thermally treated glass G4Ce, the partial substitution of
eO2 at the expense of CaO does not lead to the formation of dif-
erent phases rather than those crystallized in glass G4. Also no
erium containing phases could be detected. The wollastonite solid
olution phase formed in glass-ceramic of G4Ce has probably the
ollowing formula:
Ca0.79, Na0.21)(Si0.98, Ce0.012)(O0.88, F0.12)3 wollastonitess5
.2. Bioactivity
The rate of the formation of hydroxyl carbonate apatite (HCA)
ayer is a measure of bioactivity and HCA formation ability is
hought to be a critical factor in facilitating the chemical ﬁxation of
iomaterials to bone tissue, and ultimately the in vivo success of the
one grafting material [27]. The mechanism of HCA-like phase for-
ation on the silica base materials in SBF solution can be explained
n terms of a chemical reaction taking place between the glass-
eramic materials and the solution [5]. When the materials get in
ontact with the SBF a partial dissolution occurs producing an ionic
xchange of Ca2+ for 2H+ within the material network leading to the
ormation of silanol groups on the surface of the glass-ceramics.
ater there is a partial dissolution of amorphous silica as SiO32−.
his fact enhances the creation of crystallization nuclei for the Ca–P
hase which can be formed from the high concentration of Ca and
 present in the medium.
There was evidence to conﬁrm the formation of apatite layer on
he surfaces of crystalline specimens with a different magnitude,
hich was sought by using the EDX/SEM and FTIR techniques after
he soaking in the SBF solution for 21 days. It is clear that the bioac-
ivity of the complete Na2O/K2O replacement in the glass-ceramic
ample (i.e. G4) is higher than that of the base glass-ceramic sam-
le G1, as indicated from the EDX patterns (Fig. 5). EDX spectra
evealed that the small peak for Si and the large peak for phos-
horus were obtained from the surface of G4 as compared with
pectra obtained from G1. This may  be attributed to the solubil-
ty of the glass-ceramic sample which was increased by Na2O/K2O
eplacement. Arcos et al. [28] suggest that the release of activa-
ion energy of Si4+ is the key to determine biological activity in the
iomedical materials. The faster the release rates of Si4+, the lower is
he release of activation energy; accordingly, the faster the degra-
ation speed, the higher the biological activity. The formation of
he apatite layer on the surface of glass-ceramics was improved by
a2O/K2O replacement due to the decrease of chemical durability
f the crystallized specimens [17].There was another evidence that conﬁrms the effect of
a2O/K2O replacement on the bioactivity of the glass-ceramic sam-
les by using FTIR technique. Fig. 6 shows the FTIR patterns of G1
nd G4 glass-ceramics, containing constant amounts of K2O and
[
[amic Societies 3 (2015) 255–261
Na2O, respectively, after soaking in SBF for 21 days. FTIR spec-
tra after SBF immersion showed single peak or a split peak at
approximately 570 cm−1. This is the most characteristic region for
apatite and other phosphates, and it corresponds to P O bond-
ing vibrations in a PO34− tetrahedron and indicates the presence
of crystalline calcium phosphates including hydroxyl apatite (HA)
and hydroxyl carbonate apatite (HCA). A single peak in this region
in G1 crystalline sample explains the formation of non-apatitic or
amorphous calcium phosphate (ACP), which is usually taken as an
indication of the presence of precursors to hydroxyapatite [29].
Whereas, the split of the peak in G4 sample at 572 and 608 cm−1 is
related to the presence of crystalline phosphate [30].
The addition of CeO2 at the expense of CaO in the G1 sample (i.e.
G1Ce) showed a positive effect on the bioactivity behaviour of the
crystallized samples in the (SBF) solution. This may  be attributed to
the presence of CeO2 in the glasses which facilitates the formation
of high temperature form of CaSiO3 (pseudo-wollastonite) together
with low temperature form (wollastonite). Pseudo-wollastonite
(CaSiO3), the high temperature form of wollastonite, displays in
its structure calcium ion chains that are easily removed by protons,
as Bailey and Reesman [31] showed it in their study of kinetics
of dissolution of the wollastonite in H2O–CO2 systems. This fact
suggests the possibility of extraction of calcium ions, from the wol-
lastonite structure, by protons from the SBF and therefore facilitates
the precipitation and formation of the HA layer on the surface of the
material. Sainz et al. [32] demonstrate that the pseudo-wollastonite
is signiﬁcantly more soluble in SBF than low temperature wol-
lastonite form CaSiO3. Pseudo-wollastonite contains needle-like
structures with signiﬁcant Ca and Si ions content that favours the
formation of an apatite layer on the surface of the wollastonite
sample [33].
5. Conclusions
Bioglass-ceramic materials were successfully produced by
studying the effects of Na2O/K2O and CeO2/CaO on crystallization
behaviour and bioactivity of the K2O–CaO–SiO2–F glass system. The
glass crystallization temperatures were shifted to lower tempera-
tures as the amount of Na2O/K2O replacement was  increased. On
the contrary, the replacement of the calcium by cerium led to a
slight increase in crystallization temperatures. The XRD indicated
that the main crystalline phases were wollastonite solid solution
and pseudo-wollastonite. The appearance of apatite layer in in vitro
test on the surface of glass-ceramics demonstrates the crystalline
materials have good bioactivity. The obtained data indicate that the
Na2O/K2O replacements stimulate the rate of samples dissolution
and thus the formation of apatite layer. The results obtained show
also that the appearance of pseudo-wollastonite phase works to
increase the bioactivity rate of the glass-ceramic formed.
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